statements with intent to mislead other persons concerning the facts stated in BLISS financial statements.The SEC found that Chakkit, then BLISS executive, imparted the statements in the company?s Q2/2013, Q3

Public Company Limited BKI: BANGKOK INSURANCE PUBLIC COMPANY LIMITED BLA: BANGKOK LIFE ASSURANCE PUBLIC COMPANY LIMITED BLISS: BLISS INTELLIGENCE PUBLIC COMPANY LIMITED BR: BANGKOK RANCH PUBLIC COMPANY

LIMITED BLA: BANGKOK LIFE ASSURANCE PUBLIC COMPANY LIMITED BLAND: BANGKOK LAND PUBLIC COMPANY LIMITED BLESS: BLESS ASSET GROUP PUBLIC COMPANY LIMITED BLISS: BLISS INTELLIGENCE PUBLIC COMPANY LIMITED BM

: BANGKOK LAND PUBLIC COMPANY LIMITED BLC: Bangkok Lab and Cosmetic Public Company Limited BLESS: BLESS ASSET GROUP PUBLIC COMPANY LIMITED BLISS: BLISS INTELLIGENCE PUBLIC COMPANY LIMITED BM: BANGKOK SHEET

[COMPANY NAME] EFORL IR010/2018 March 20, 2018 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2017 To President The Stock Exchange of Thailand 1. Overview financial

[COMPANY NAME] Ref.: EFORL IR008/2019 March 7, 2019 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2018 To President The Stock Exchange of Thailand 1. Overview financial

[COMPANY NAME] Ref.:EFORL020/2018 May 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 31 March 2018 To President The Stock Exchange of Thailand 1. Overview financial

[COMPANY NAME] Ref.: EFORL IR 037/2018 August 15, 2018 Subject: Notification of allocation and subscription of capital increase ordinary shares of WCI Holding Public Company Limited. (Edit) To: The

[COMPANY NAME] Ref.: EFORL IR007/2020 March 4, 2020 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2019 To President The Stock Exchange of Thailand 1. Overview financial

Company Profile - DOD BIOTECH PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 28 August 2022 21:45 ​ ​ Company Profile DOD BIOTECH PUBLIC COMPANY LIMITED Please